Anne Hyland

Anne Hyland

Corporate Officer/Principal chez
London Stock Exchange Plc
66 ans
Health Technology
Consumer Services
Commercial Services

Profil

Anne Philomena Hyland is currently a Member-Primary Markets Group at London Stock Exchange Plc.
She previously worked as a Finance Director at Celltech Group Plc and Medeva Plc.
From 2010 to 2013, she was the CFO, Secretary & Executive Director at Vectura Group Ltd. She also served as an Independent Non-Executive Director at Elementis Plc from 2013 to 2022 and at Clinigen Ltd. from 2018 to 2022.
She was the Chief Financial Officer & Director at BBI Diagnostics Group 2 Plc and the Chief Financial Officer & Secretary at BBI Diagnostics Group Ltd. She worked as an Audit Manager at KPMG Audit Plc.
From 2015 to 2021, she was the Chief Financial Officer & Secretary at Kymab Ltd. She was a Trustee at Sustrans Ltd. from 2012 to 2017.
Ms. Hyland received an undergraduate degree from Trinity College Dublin.

Postes actifs de Anne Hyland

SociétésPosteDébut
Corporate Officer/Principal -

Anciens postes connus de Anne Hyland

SociétésPosteFin
MEREO BIOPHARMA GROUP PLC Directeur/Membre du Conseil 10/11/2022
ELEMENTIS PLC Directeur/Membre du Conseil 26/04/2022
CLINIGEN GROUP PLC Directeur/Membre du Conseil 01/04/2022
Directeur Financier/CFO 01/04/2021
Directeur/Membre du Conseil 01/01/2017
Voir l'expérience en détail de Anne Hyland

Formation de Anne Hyland

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Consumer Services

Commercial Services

Finance

Health Technology

Consumer Services

Commercial Services

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Anne Hyland
🔇